G1FI34.SA
Gold Fields Limited
São PauloBRLEQUITY
DELAYED
Last price
123.60
▲ 5.59 (4.74%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
124.00
Prev close
118.01
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
—
52W range
— – 160.05
Day trading desk
Gap from prior close
+5.08%
Prior close 118.01
VWAP
123.67
-0.05% from price
Relative volume
—
—
Session range
2.85%
122.28 – 125.76
Position in range
38%
Mid range
ATR (14D)
5.19
4.20% of price
Prior day high
118.77
PDH
Prior day low
112.09
PDL
Bid / ask spread
—
Quote not published
Session volume
18.22K
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+17.71%
+19.1%
1M
+50.42%
+46.7%
3M
+22.89%
+19.8%
6M
-11.37%
-22.4%
YTD
+2.18%
-10.1%
1Y
+53.56%
+33.6%
3Y
+285.05%
+210.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on G1FI34.SA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.75B | $5.20B | $4.50B | $4.29B | +68.2% |
| Operating revenue | $8.75B | $5.20B | $4.50B | $4.29B | +68.2% |
| Cost of revenue | $3.91B | $2.99B | $2.86B | $2.72B | +30.8% |
| Gross profit | $4.84B | $2.21B | $1.64B | $1.57B | +118.9% |
| Selling, general & admin | $68.60M | $18.90M | $64.90M | $35.90M | +263.0% |
| Total operating expense | $433.10M | $117.00M | $170.20M | $132.20M | +270.2% |
| Operating income | $4.41B | $2.09B | $1.47B | $1.44B | +110.5% |
| Net interest income | -$67.40M | -$21.80M | -$38.30M | -$59.30M | -209.2% |
| Pre-tax income | $5.29B | $1.99B | $1.21B | $1.15B | +166.4% |
| Tax provision | $1.65B | $697.10M | $465.10M | $442.10M | +136.6% |
| Net income | $3.57B | $1.25B | $703.30M | $711.00M | +186.5% |
| Net income to common | $3.57B | $1.25B | $703.30M | $711.00M | +186.5% |
| Basic EPS | 2.00 | 0.70 | 0.40 | 0.40 | +187.1% |
| Diluted EPS | 1.97 | 0.69 | 0.39 | 0.39 | +185.5% |
| EBIT | $5.42B | $2.04B | $1.27B | $1.22B | +165.7% |
| EBITDA | $6.34B | $2.67B | $2.07B | $2.07B | +137.7% |
| Basic shares | 1.79B | 1.79B | 1.79B | 1.78B | +0.0% |
| Diluted shares | 1.79B | 1.79B | 1.79B | 1.79B | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.78B | $860.20M | $648.70M | $769.40M | +106.8% |
| Cash & short-term investments | $1.78B | $860.20M | $648.70M | $769.40M | +106.8% |
| Accounts receivable | $144.10M | $152.70M | $68.70M | $55.80M | -5.6% |
| Inventory | $782.60M | $699.30M | $827.90M | $759.00M | +11.9% |
| Total current assets | $3.05B | $1.95B | $1.89B | $1.80B | +56.5% |
| Property, plant & equipment | $11.34B | $7.30B | $5.07B | $4.82B | +55.3% |
| Total assets | $15.23B | $10.14B | $8.23B | $7.34B | +50.1% |
| Total current liabilities | $1.70B | $1.71B | $1.51B | $785.40M | -0.6% |
| Current debt | $178.70M | $719.10M | $583.10M | — | -75.1% |
| Long-term debt | $2.56B | $1.78B | $653.40M | $1.08B | +44.1% |
| Total debt | $3.22B | $2.95B | $1.67B | $1.47B | +9.3% |
| Total liabilities | $6.55B | $4.78B | $3.61B | $3.00B | +37.2% |
| Retained earnings | $6.68B | $3.86B | $2.96B | $2.63B | +73.1% |
| Shareholder equity | $8.43B | $5.20B | $4.48B | $4.21B | +62.1% |
| Working capital | $1.35B | $237.40M | $381.90M | $1.02B | +468.0% |
| Net tangible assets | $8.43B | $5.20B | $4.48B | $4.21B | +62.1% |
| Shares issued | 895.02M | 895.02M | 893.54M | 891.38M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $3.65B | $1.29B | $745.20M | $708.70M | +182.5% |
| Depreciation & amortisation | $920.40M | $627.40M | $795.30M | $844.30M | +46.7% |
| Stock-based compensation | $25.40M | $4.40M | $9.10M | $6.90M | +477.3% |
| Change in working capital | $187.40M | $13.90M | -$199.10M | -$134.20M | +1,248.2% |
| Operating cash flow | $3.77B | $1.61B | $1.19B | $1.38B | +134.7% |
| Capital expenditure | -$1.40B | -$1.18B | -$1.05B | -$1.07B | -18.2% |
| Investing cash flow | -$2.77B | -$2.59B | -$1.37B | -$1.07B | -6.8% |
| Share buybacks | -$36.30M | $0 | $0 | — | — |
| Financing cash flow | -$173.30M | $1.21B | $82.40M | -$56.90M | -114.3% |
| Free cash flow | $2.37B | $423.60M | $138.10M | $309.90M | +460.4% |
| End cash position | $1.78B | $860.20M | $648.70M | $769.40M | +106.8% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.78B | $1.07B | $860.20M | +66.8% |
| Cash & short-term investments | $1.78B | $1.07B | $860.20M | +66.8% |
| Accounts receivable | $144.10M | — | $152.70M | — |
| Inventory | $782.60M | — | $699.30M | — |
| Total current assets | $3.05B | $2.08B | $1.95B | +46.4% |
| Property, plant & equipment | $11.34B | $7.94B | $7.30B | +42.8% |
| Total assets | $15.23B | $10.86B | $10.14B | +40.2% |
| Total current liabilities | $1.70B | $1.10B | $1.71B | +54.0% |
| Current debt | $178.70M | — | $719.10M | — |
| Long-term debt | $2.56B | $2.12B | $1.78B | +20.7% |
| Total debt | $3.22B | $2.55B | $2.95B | +26.1% |
| Total liabilities | $6.55B | $4.61B | $4.78B | +42.1% |
| Retained earnings | $6.68B | $4.54B | $3.86B | +47.1% |
| Shareholder equity | $8.43B | $6.08B | $5.20B | +38.6% |
| Working capital | $1.35B | $978.10M | $237.40M | +37.9% |
| Net tangible assets | $8.43B | $6.08B | $5.20B | +38.6% |
| Shares issued | 895.02M | 895.02M | 895.02M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
109.18
+13.21% from price
SMA 20
98.82
+25.08% from price
SMA 50
92.11
+34.19% from price
SMA 100
100.10
+23.48% from price
SMA 200
112.47
+9.90% from price
EMA 12
107.94
+14.51% from price
EMA 26
100.21
+23.34% from price
EMA 50
97.29
+27.04% from price
RSI (14)
81.0
Overbought
MACD (12,26,9)
7.72
Hist 2.53
ATR (14)
5.19
4.20% of price
Realised vol 30D
48.7%
Annualised
Bollinger upper
123.71
20, 2σ
Bollinger lower
73.92
20, 2σ
50 / 200 cross
Death
92.11 vs 112.47
Trend bias
Above 200
+9.90%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.50
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
48.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-49.6%
Peak to trough
Max drawdown 5Y
-55.2%
Peak to trough
ATR 14
5.19
4.20% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Orum to begin Phase I trial of ORM-1153 after FDA clearance
Clinical Trials Arena · 1m ago
Johnson & Johnson’s multiple myeloma treatment secures EC approval
Pharmaceutical Technology · 3m ago
GE Vernova Introduces Medium-Voltage UPS for AI Data Centers
MT Newswires · 4m ago
Truist Securities Adjusts Price Target on Aveanna Healthcare to $15 From $11, Keeps Hold Rating
MT Newswires · 5m ago
TAT defines The Year of Transformation as Thailand's 2027 tourism direction
PR Newswire · 5m ago
Robo.ai Inc. Reports First Half 2026 Financial Results
PR Newswire · 5m ago
Property Taxes Up $743.8 Million; Homeowners Hit Again
PR Newswire · 5m ago
Monster Energy's Reinier Defeats Roman Dolidze via TKO in UFC Light Heavyweight Debut at UFC Fight Night in Sacramento
PR Newswire · 5m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.